LiveDr Reddy’s Laboratories has launched Tetrabenazine tablets in the US markets.
Dr Reddy’s has launched Tetrabenazine tablets, which is a therapeutic equivalent generic version of Xenazine in United States, approved by the US Food and Drug Administration (USFDA).
Further, Tetrabenazine tablets are available in strengths of 12.5 mg and 25 mg, and each strength is available in a bottle count size of 112.
